# ALBERT EINSTEIN COLLEGE OF MEDICINE: Angiotensin II type 1 receptor autoantibody as a Biomarker for Identification and Targeted treatment of Individuals at risk for Alzheimer’s Disease (ABIT-AD)

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ALBERT EINSTEIN COLLEGE OF MEDICINE |
| Location | BRONX, NY |
| Project | Angiotensin II type 1 receptor autoantibody as a Biomarker for Identification and Targeted treatment of Individuals at risk for Alzheimer’s Disease (ABIT-AD) |
| Project number | 1R01AG092866-01A1 |
| Mechanism | R01 |
| Institute | National Institute on Aging |
| Award | $731,117 |
| Awarded | 2026-09-16 |
| Project period | 2026-09-16 to 2031-05-31 |
| UEI | H6N1ZF5HJ2G3 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11365316). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.